|Alternative name||Small Molecule-miRNA Network-Based Inference|
|Restrictions to use||None|
|Data access||File download, Browse|
|User data submission||Not allowed|
- person_outline Yun Tang <>
- person_outline Jianwen Liu <>
Publication for Small Molecule-miRNA Network-Based Inference
Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China; State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China; Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Center for Complex Networks Research, Northeastern University, Boston, MA, USA
SMiR-NBI funding source(s)
Supported by the National Natural Science Foundation of China (Grant 81373329 and 81573020), the 863 Project (Grant 2012AA020308), the Fundamental Research Funds for the Central Universities (Grant WY1113007), and the 111 Project (Grant B07023).
This database contained both validated and predicted links among small molecules, miRNAs and diseases, aimed at studying their relationships to identify pharmacogenomic biomarkers. This is a good resource to check the knowledge base and find potential relationships predicted by the high-performance NBI method and worth experimental validation.